drugset / Trial / NCT01722604
Therapeutic Equivalence Study of Generic Brinzolamide vs Azopt
RandomizedParallel-groupDouble-blindHealth-services research
Summary
The main purpose of this prospective study is to demonstrate the therapeutic equivalence of topical brinzolamide dosed three times daily compared with AzoptTM (brinzolamide ophthalmic suspension 1%) dosed three times daily in IOP reduction in patients with POAG or OH.
Timeline
- Start
- 2012-01
- Primary completion
- 2012-09
- Completion
- 2012-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Brinzolamide | Small molecule | 1 % | Topical |